A regulatory role for CHD2 in myelopoiesis

References

• Alvarez-Errico D, Vento-Tormo R, Sieweke M, et al. Epigenetic control of myeloid cell differentiation, identity and function. Nat Rev Immunol. 2015 Jan;15(1):7–17.
   PubMed Web of Science ®Google Scholar
• Prasad P, Ronnerblad M, Arner E, et al. High-throughput transcription profiling identifies putative epigenetic regulators of hematopoiesis. Blood. 2014 Apr 24;123(17):e46–57.
   PubMed Web of Science ®Google Scholar
• Rönnerblad MAR, Olofsson T, Douagi I, et al.; FANTOM consortium. Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation. Blood. 2014;123:17.
   Web of Science ®Google Scholar
• Haladyna JNYT, Neff T, Bernt KM. Epigenetic modifiers in normal and malignant hematopoiesis. Epigenomics. 2015;7:2.
   Web of Science ®Google Scholar
• Di Carlo V, Mocavini I, Di Croce L. Polycomb complexes in normal and malignant hematopoiesis. J Cell Biol. 2019 Jan 7;218(1):55–69.
   PubMed Web of Science ®Google Scholar
• Eriksson A, Lennartsson A, Lehmann S. Epigenetic aberrations in acute myeloid leukemia: early key events during leukemogenesis. Exp Hematol. 2015 Aug;43(8):609–624.
   PubMed Web of Science ®Google Scholar
• Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015 Sep 17;373(12):1136–1152.
   PubMed Web of Science ®Google Scholar
• Narlikar GJ, Sundaramoorthy R, Owen-Hughes T. Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes. Cell. 2013 Aug 1;154(3):490–503.
   PubMed Web of Science ®Google Scholar
• Burkhardt L, Fuchs S, Krohn A, et al. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. Cancer Res. 2013 May 1;73(9):2795–2805.
   PubMed Web of Science ®Google Scholar
• Gaspar-Maia A, Alajem A, Polesso F, et al. Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature. 2009 Aug 13;460(7257):863–868.
   PubMed Web of Science ®Google Scholar
• Huang S, Gulzar ZG, Salari K, et al. Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness. Oncogene. 2012 Sep 13;31(37):4164–4170.
   PubMed Web of Science ®Google Scholar
• Heshmati Y, Turkoz G, Harisankar A, et al. The chromatin-remodeling factor CHD4 is required for maintenance of childhood acute myeloid leukemia. Haematologica. 2018 Jul;103(7):1169–1181.
   PubMed Web of Science ®Google Scholar
• Huang R, Zhao L, Chen H, et al. Megakaryocytic differentiation of K562 cells induced by PMA reduced the activity of respiratory chain complex IV. PLoS One. 2014;9(5):e96246.
   PubMed Web of Science ®Google Scholar
• Schmierer B, Botla SK, Zhang J, et al. CRISPR/Cas9 screening using unique molecular identifiers. Mol Syst Biol. 2017 Oct 9;13(10):945.
   PubMed Web of Science ®Google Scholar
• Lecona E, Rojas LA, Bonasio R, et al. Polycomb protein SCML2 regulates the cell cycle by binding and modulating CDK/CYCLIN/p21 complexes. PLoS Biol. 2013 Dec;11(12):e1001737.
   PubMed Web of Science ®Google Scholar
• Wu MY, Eldin KW, Beaudet AL. Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genes. J Natl Cancer Inst. 2008 Sep 3;100(17):1247–1259.
   PubMedGoogle Scholar
• Yang W, Ernst P. SET/MLL family proteins in hematopoiesis and leukemia. Int J Hematol. 2017 Jan;105(1):7–16.
   PubMed Web of Science ®Google Scholar
• Jones M, Chase J, Brinkmeier M, et al. Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells. J Clin Invest. 2015 May;125(5):2007–2020.
   PubMed Web of Science ®Google Scholar
• Siggens L, Cordeddu L, Ronnerblad M, et al. Transcription-coupled recruitment of human CHD1 and CHD2 influences chromatin accessibility and histone H3 and H3.3 occupancy at active chromatin regions. Epigenetics Chromatin. 2015;8(1):4.
   Web of Science ®Google Scholar
• Forrest AR, Kawaji H, Rehli M, et al.; Consortium F, the RP, Clst. A promoter-level mammalian expression atlas. Nature. 2014 Mar 27;507(7493):462–470.
   PubMed Web of Science ®Google Scholar
• Ley TJ, Miller C; Cancer Genome Atlas Research N. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059–2074.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401–404.
   PubMed Web of Science ®Google Scholar
• Jianjiong Gao BAA, Dogrusoz U, Dresdner G, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6:269.
   Web of Science ®Google Scholar
• Liu JC, Ferreira CG, Yusufzai T. Human CHD2 is a chromatin assembly ATPase regulated by its chromo- and DNA-binding domains. J Biol Chem. 2015 Jan 2;290(1):25–34.
   PubMed Web of Science ®Google Scholar
• Nagarajan P, Onami TM, Rajagopalan S, et al. Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis. Oncogene. 2009 Feb 26;28(8):1053–1062.
   PubMed Web of Science ®Google Scholar
• Marfella CG, Ohkawa Y, Coles AH, et al. Mutation of the SNF2 family member Chd2 affects mouse development and survival. J Cell Physiol. 2006 Oct;209(1):162–171.
   PubMed Web of Science ®Google Scholar
• Meganathan K, Lewis EMA, Gontarz P, et al. Regulatory networks specifying cortical interneurons from human embryonic stem cells reveal roles for CHD2 in interneuron development. Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11180–E11189.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Khoshkhoo S, Frankowski JC, et al. Chd2 is necessary for neural circuit development and long-term memory. Neuron. 2018 December 5;100(5):13.
   Web of Science ®Google Scholar
• Shen T, Ji F, Yuan Z, et al. CHD2 is required for embryonic neurogenesis in the developing cerebral cortex. Stem Cells. 2015 Jun;33(6):1794–1806.
   PubMed Web of Science ®Google Scholar
• Capelli LP, Krepischi AC, Gurgel-Giannetti J, et al. Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency. Eur J Med Genet. 2012 Feb;55(2):132–134.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Nagarajan P, Wall J, et al. Disruption of chromodomain helicase DNA binding protein 2 (CHD2) causes scoliosis. Am J Med Genet A. 2008 May 1;146A(9):1117–1127.
   PubMed Web of Science ®Google Scholar
• Whiteford ML, Baird C, Kinmond S, et al. A child with bisatellited, dicentric chromosome 15 arising from a maternal paracentric inversion of chromosome 15q. J Med Genet. 2000 Aug;37(8):E11.
   Google Scholar
• Wilson GN, Sauder SE, Bush M, et al. Phenotypic delineation of ring chromosome 15 and Russell-Silver syndromes. J Med Genet. 1985 Jun;22(3):233–6.
   Web of Science ®Google Scholar
• Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet. 2011 Dec 11;44(1):47–52.
   PubMed Web of Science ®Google Scholar
• Harada A, Okada S, Konno D, et al. Chd2 interacts with H3.3 to determine myogenic cell fate. Embo J. 2012 Jun 29;31(13):2994–3007.
   PubMed Web of Science ®Google Scholar
• Tan FGS, Mbeunkui F, Thomas R, et al. Essential role for ALCAM gene silencing in megakaryocytic differentiation of K562 cells. BMC Mol Biol. 2010 Dec 2;11:91.
   PubMed Web of Science ®Google Scholar
• Doench JG, Fusi N, Sullender M, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016 Feb;34(2):184–191.
   PubMed Web of Science ®Google Scholar
• Medvedeva YA, Lennartsson A, Ehsani R, et al. EpiFactors: a comprehensive database of human epigenetic factors and complexes. Database (Oxford). 2015;2015:bav067.
   PubMedGoogle Scholar
• Bajpe PK, Prahallad A, Horlings H, et al. A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity. Oncogene. 2015 Jan 22;34(4):531–536.
   PubMed Web of Science ®Google Scholar
• Li W, Xu H, Xiao T, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 2014;15(12):554.
   Web of Science ®Google Scholar
• Eden E, Navon R, Steinfeld I, et al. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009 Feb;3(10):48.
   Google Scholar
• Supek F, Bosnjak M, Skunca N, et al. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One. 2011;6(7):e21800.
   PubMed Web of Science ®Google Scholar
• Zetsche B, Heidenreich M, Mohanraju P, et al. Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array. Nat Biotechnol. 2017 Jan;35(1):31–34.
   PubMed Web of Science ®Google Scholar
• Miller GD, Woessner DW, Sirch MJ, et al. Multidomain targeting of Bcr-Abl by disruption of oligomerization and tyrosine kinase inhibition: toward eradication of CML. Mol Pharm. 2013 Sep 3;10(9):3475–3483.
   PubMedGoogle Scholar
• Marks AJ, Cooper MS, Anderson RJ, et al. Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptide. Cancer Res. 2005 Mar 15;65(6):2373–7.
   Web of Science ®Google Scholar